World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
48
Citations
9525
World Ranking
4663
National Ranking
6

Alejandro G. Schijman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Alejandro G. Schijman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 138 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Alejandro G. Schijman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Alejandro G. Schijman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Alejandro G. Schijman is affiliated with the National Scientific and Technical Research Council in Argentina. Their primary field of study is Medicine, encompassing 82 publications. Within Medicine, Schijman's work focuses on several specialized subfields, including Epidemiology, Public Health, Environmental and Occupational Health, Insect Science, Parasitology, and Organic Chemistry.

Schijman's research has concentrated extensively on parasitic diseases, specifically Trypanosoma species. This focus is reflected in major topical areas including Trypanosoma species research and implications, Research on Leishmaniasis Studies, Insect symbiosis and bacterial influences, Synthesis and Biological Evaluation, Parasitic Diseases Research and Treatment, Biochemical and Molecular Research, and Parasites and Host Interactions.

Notable recent papers authored or co-authored by Schijman include:

  • New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial, 2021, The Lancet Infectious Diseases
  • A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease, 2022, Clinical Infectious Diseases
  • Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus, 2020, PLoS neglected tropical diseases
  • Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation, 2020, PLoS neglected tropical diseases
  • New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia, 2021, BMJ Open

Schijman collaborates frequently with a network of researchers. Common co-authors include Joaquím Gascón, María-Jesús Pinazo, Julio Alonso-Padilla, Arturo Muñoz-Calderón, and Faustino Torrico.

Their work is published frequently in certain scientific journals, including:

  • PLoS neglected tropical diseases
  • Journal of Molecular Diagnostics
  • BMJ Open
  • Memórias do Instituto Oswaldo Cruz
  • The Lancet Microbe

The researcher's studies cover a broad range of topics related to parasitic infections and their treatment, diagnostic techniques, and epidemiological impacts, with a strong emphasis on Chagas disease and related treatments. The combination of clinical trials, diagnostic development, and epidemiological studies marks the multifaceted approach in their contributions to medical science and parasitology.

Best Publications

  • A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

    B Zingales;SG Andrade;Briones;DA Campbell

  • The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.

    Bianca Zingales;Michael A. Miles;David A. Campbell;Michel Tibayrenc

  • International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.

    Alejandro G. Schijman;Margarita Bisio;Liliana Orellana;Mariela Sued

  • Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients.

    Tomás Duffy;Margarita María Catalina Bisio;Jaime Marcelo Altcheh;Juan Miguel Burgos

  • Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

    Faustino Torrico;Joaquim Gascon;Lourdes Ortiz;Cristina Alonso-Vega

  • Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples.

    Tomas Duffy;Carolina I. Cura;Juan C. Ramirez;Teresa Abate

  • Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction

    Alejandro Gabriel Schijman;Jaime Marcelo Altcheh;Juan Miguel Burgos;Miguel Angel Biancardi

  • Towards a paradigm shift in the treatment of chronic Chagas disease

    R. Viotti;B. Alarcón de Noya;T. Araujo-Jorge;M. J. Grijalva

  • Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease

    Juan Miguel Burgos;Jaime Marcelo Altcheh;Margarita María Catalina Bisio;Tomás Duffy

  • Molecular Identification of Trypanosoma cruzi Discrete Typing Units in End-Stage Chronic Chagas Heart Disease and Reactivation after Heart Transplantation

    Juan Miguel Burgos;Mirta Diez;Carlos Vigliano;Margarita Bisio

  • Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients

    Juan Carlos Ramírez;Carolina Inés Cura;Otacilio da Cruz Moreira;Eliane Lages-Silva

  • Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

    Gustavo Benaim;John M. Sanders;Yael Garcia-Marchán;Claudia Colina

  • Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation.

    M. Diez;L. Favaloro;A. Bertolotti;J. M. Burgos

  • New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

    Faustino Torrico;Joaquim Gascón;Fabiana Barreira;Bethania Blum

  • Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced-leader genes

    Carolina I. Cura;Ana M. Mejía-Jaramillo;Tomás Duffy;Juan M. Burgos

  • Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease.

    Mariano J. Levin;Enrique Mesri;Richard Benarous;Gabriela Levitus

  • Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina.

    Marta Victoria Cardinal;Marta A. Lauricella;Leonardo A. Ceballos;Leonardo Lanati

  • Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity

    Bianca Zingales;Michael A. Miles;Carolina B. Moraes;Alejandro Luquetti

  • Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.

    Alejandro O. Luquetti;Carlos Ponce;Elisa Ponce;Javan Esfandiari

  • Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women.

    Yves Carlier;Yves Carlier;Jaime Altcheh;Andrea Angheben;Hector Freilij

  • Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach

    Yvonne Qvarnstrom;Alejandro Gabriel Schijman;Vincent Veron;Christine Aznar

Frequent Co-Authors

Mariano J. Levin
Mariano J. Levin University of Buenos Aires
Joaquim Gascon
Joaquim Gascon University of Barcelona
Ricardo E. Gürtler
Ricardo E. Gürtler University of Buenos Aires
Felipe Guhl
Felipe Guhl Universidad de Los Andes
Andrea M. Macedo
Andrea M. Macedo Universidade Federal de Minas Gerais
Uriel Kitron
Uriel Kitron Emory University
Bianca Zingales
Bianca Zingales Universidade de São Paulo
Mitermayer G. Reis
Mitermayer G. Reis Oswaldo Cruz Foundation
Igor C. Almeida
Igor C. Almeida The University of Texas at El Paso
Michel Tibayrenc
Michel Tibayrenc Institut de Recherche pour le Développement

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary fields and career options. Many students consider expanding their expertise through online medical degrees, which offer flexible, accessible pathways into healthcare professions. These programs allow learners to balance studies with work or personal commitments while building a strong foundation in medical sciences.

Public health is another complementary area, especially for those interested in community health and epidemiology. There are numerous easy admission online MPH programs that provide practical skills for disease prevention and health promotion, ideal for microbiology graduates aiming to influence public health policy or research.

For students drawn to supporting children's emotional needs in healthcare settings, obtaining a CCLS certification can be a valuable step. This credential prepares professionals to improve pediatric patient experiences through specialized care and advocacy.

Importantly, many online programs are inclusive and accessible, including online colleges that accept felons. This inclusivity broadens opportunities for non-traditional students seeking to advance their education and careers in microbiology-related fields.

Best Scientists Citing Alejandro G. Schijman

Trending Scientists

Recently Published Articles